CompanyPrivateParsippany, NJ

Castle Creek Biosciences, Inc

SEC EDGAR ClinicalTrials.gov

SCHEDULE 13D/ANov 3Latest SEC filing

Form DFeb 25$75M sold

October 2026

Pelthos Therapeutics to merge with Castle Creek Biosciences in stock-and-milestone deal

Oct 30FinancingPelthos Therapeutics Inc.